On September 24, Gelunhui reported that Special Treat Jingfeng (000908.SZ) announced that the company recently received a notice from Mr. Ye Xiangwu regarding the completion of the shareholding plan of Hunan Jingfeng Pharmaceutical Co., Ltd. As of the disclosure date of the announcement, Mr. Ye Xiangwu has cumulatively increased the company's shareholding by 1.0448 million shares through the Shenzhen Stock Exchange trading system in a centralized bidding trading manner, accounting for 0.12% of the total share capital of the company. The total amount of the shareholding is 2,002,940 yuan (excluding transaction costs), and the shareholding amount has reached the lower limit of this shareholding plan. This shareholding plan has been completed.